Monounsaturated fatty acid for preventing and/or treating skin complexion imperfections
09730905 · 2017-08-15
Assignee
Inventors
Cpc classification
A61K31/191
HUMAN NECESSITIES
A23V2002/00
HUMAN NECESSITIES
A61K8/99
HUMAN NECESSITIES
A23V2002/00
HUMAN NECESSITIES
A61K31/20
HUMAN NECESSITIES
A23V2200/3204
HUMAN NECESSITIES
A23V2200/3204
HUMAN NECESSITIES
A61K31/341
HUMAN NECESSITIES
A23L33/135
HUMAN NECESSITIES
A23V2200/318
HUMAN NECESSITIES
A23L33/105
HUMAN NECESSITIES
A61K31/194
HUMAN NECESSITIES
A61K45/06
HUMAN NECESSITIES
A23K20/158
HUMAN NECESSITIES
A61K31/201
HUMAN NECESSITIES
A23L33/115
HUMAN NECESSITIES
A61K36/23
HUMAN NECESSITIES
A23V2200/318
HUMAN NECESSITIES
International classification
A61K45/06
HUMAN NECESSITIES
A23L33/135
HUMAN NECESSITIES
A61K31/201
HUMAN NECESSITIES
A61K8/92
HUMAN NECESSITIES
A61K8/99
HUMAN NECESSITIES
A61K36/23
HUMAN NECESSITIES
A23L33/105
HUMAN NECESSITIES
A23P10/30
HUMAN NECESSITIES
A23K20/158
HUMAN NECESSITIES
A61K31/191
HUMAN NECESSITIES
A61K31/194
HUMAN NECESSITIES
A61K31/20
HUMAN NECESSITIES
A61K31/341
HUMAN NECESSITIES
Abstract
The invention relates to the oral or nutraceutical cosmetic use of an effective amount of at least one monounsaturated fatty acid, a salt thereof and/or an ester thereof, as an active agent for treating and/or preventing skin complexion imperfections.
Claims
1. A cosmetic method for revealing the radiance of the skin complexion comprising orally administering an effective amount of at least one monounsaturated fatty acid, a salt thereof and/or an ester thereof to a subject in need thereof, said complexion being affected by excessive secretion of sebum.
2. The method of claim 1, in which the skin is the skin of the face, the neck and/or the neckline.
3. The method of claim 1, in which said monounsaturated fatty acid, salt thereof and/or ester thereof is used in an isolated form or in a plant extract.
4. The method of claim 1, in which the monounsaturated fatty acid, salt thereof and/or ester thereof is used in an oral composition, and in which the content of said monounsaturated fatty acid, salt thereof and/or ester thereof is such that the daily dose ranges from 0.5 to 2500 mg/day.
5. The method of claim 1, in which said monounsaturated fatty acid is petroselinic acid.
6. The method of claim 5, in which said petroselinic acid is used in the form of an oil from an Umbellifera plant or from Geranium sanguineum.
7. The method of claim 6, in which said Umbellifera plant oil is chosen from the seed oils of coriander, chervil, carrot, celery, cumin, caraway, parsley and dill, and mixtures thereof.
8. The method of claim 1, in which said monounsaturated fatty acid is used in combination with at least one additional cosmetic active agent, chosen from vitamin B3, B5, B6, B8, C, or E, carotenoids, curcuminoids, niacin, flavonoids, one or more divalent mineral cations, bacteria or bacterial extracts derived from non-photosynthetic, filamentous bacteria, and probiotic microorganisms.
9. The method of claim 8, in which said probiotic microorganism is chosen from microorganisms of the genus Lactobacillus or Bifidobacterium.
10. The method of claim 8, in which the probiotic microorganism is a lactic acid bacterium.
Description
EXAMPLES
Example 1
(1) Oral Compositions
Example 1A: Stick in Powder Form
(2) TABLE-US-00001 Active principle Lactobacillus paracasei ST11 10.sup.10 cfu Bifidobacterium lactis Bb12 10.sup.10 cfu Calcium citrate 50 mg Petroselinic acid 100 mg Excipient Xanthan gum 0.8 mg Sodium benzoate 0.2 mg Maltodextrin qs 30 g
(3) One stick can be taken per day.
(4) Taking such a stick daily for about a week makes it possible to give the skin a uniform and luminous complexion.
Example 1B: Stick in Powder Form
(5) TABLE-US-00002 Active principle Magnesium gluconate 50 Lactobacillus paracasei ST11 5 × 10.sup.8 cfu Bifidobacterium lactis Bb12 5 × 10.sup.8 cfu Calcium citrate 200 Coriander oil 250 Excipient Xanthan gum 0.8 mg Sodium benzoate 0.2 mg Maltodextrin qs 30 g
(6) One stick can be taken per day.
(7) Taking such a stick daily for about one week makes it possible to significantly reduce dyschromia and to give the skin a uniform, luminous and radiant complexion.
Example 1C: Capsule
(8) TABLE-US-00003 Active principle mg/capsule Coriander oil 150 Vitamin C 60 Magnesium stearate 0.02
(9) One to three of these capsules may be taken per day.
(10) Taking such a capsule daily for about one week makes it possible to significantly reduce dyschromia, redness and skin imperfections and to give the skin a uniform, luminous and radiant complexion.
Example 1D: Formulation of Sugar-Coated Tablet Type
(11) TABLE-US-00004 mg/coated tablet Active materials Coriander oil 550 Excipient of the core of the coated tablet Microcrystalline cellulose 70 Encompress ™ 60 Magnesium stearate 3 Anhydrous colloidal silica 1 Coating agent Shellac 5 Talc 61 Sucrose 250 Polyvidone 6 Titanium dioxide 0.3 Coloring agent 5
(12) This type of sugar-coated tablet may be taken 1 to 3 times per day.
(13) Taking such a sugar-coated tablet daily for about one week makes it possible to significantly reduce dyschromia and skin imperfections and to give the skin a uniform, luminous and radiant complexion.
Example 1E: Formulation of Sugar-Coated Tablet Type
(14) TABLE-US-00005 mg/coated tablet Active materials Coriander oil 250 Lactobacillus johnsonii 10.sup.9 cfu Excipient of the core of the coated tablet Microcrystalline cellulose 70 Encompress ™ 60 Magnesium stearate 3 Anhydrous colloidal silica 1 Coating agent Shellac 5 Talc 61 Sucrose 250 Polyvidone 6 Titanium dioxide 0.3 Coloring agent 5
(15) This type of sugar-coated tablet may be taken 1 to 3 times per day.
(16) Taking such a sugar-coated tablet daily for about one week makes it possible to significantly reduce dyschromia and to give the skin a uniform, luminous and radiant complexion.